全文获取类型
收费全文 | 1183篇 |
免费 | 64篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 43篇 |
妇产科学 | 7篇 |
基础医学 | 135篇 |
口腔科学 | 9篇 |
临床医学 | 84篇 |
内科学 | 257篇 |
皮肤病学 | 12篇 |
神经病学 | 20篇 |
特种医学 | 317篇 |
外国民族医学 | 1篇 |
外科学 | 134篇 |
综合类 | 12篇 |
预防医学 | 34篇 |
眼科学 | 4篇 |
药学 | 117篇 |
中国医学 | 1篇 |
肿瘤学 | 45篇 |
出版年
2022年 | 5篇 |
2021年 | 14篇 |
2020年 | 4篇 |
2018年 | 11篇 |
2017年 | 5篇 |
2016年 | 9篇 |
2015年 | 13篇 |
2014年 | 9篇 |
2013年 | 14篇 |
2012年 | 14篇 |
2011年 | 24篇 |
2010年 | 20篇 |
2009年 | 21篇 |
2008年 | 22篇 |
2007年 | 35篇 |
2006年 | 29篇 |
2005年 | 22篇 |
2004年 | 19篇 |
2003年 | 21篇 |
2002年 | 27篇 |
2001年 | 26篇 |
2000年 | 25篇 |
1999年 | 35篇 |
1998年 | 56篇 |
1997年 | 45篇 |
1996年 | 65篇 |
1995年 | 45篇 |
1994年 | 39篇 |
1993年 | 42篇 |
1992年 | 21篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 47篇 |
1988年 | 48篇 |
1987年 | 41篇 |
1986年 | 35篇 |
1985年 | 51篇 |
1984年 | 32篇 |
1983年 | 30篇 |
1982年 | 29篇 |
1981年 | 28篇 |
1980年 | 15篇 |
1979年 | 6篇 |
1978年 | 10篇 |
1977年 | 36篇 |
1976年 | 20篇 |
1975年 | 19篇 |
1973年 | 6篇 |
1971年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有1269条查询结果,搜索用时 15 毫秒
91.
目的:分析血管紧张素原基因启动子区A-20C和A-6G单核苷酸多态性与蒙古族人群原发性高血压的相关性。方法:实验于2005-08/2006-01在北京华大实验室完成。选取对象均为生活在内蒙古乌拉特后旗的蒙古族牧民,三代血亲内无其他民族。采用基因测序技术对内蒙古蒙古族人群中107例原发性高血压患者和108例正常对照者进行A-20C和A-6G基因分型,观察高血压组和正常对照组不同基因型的分布和等位基因频率的差异。结果:①两组受试者在性别、年龄及吸烟、饮酒、体质量指数和临床化验检查指标有较好的匹配(P均>0.05)。②两组血管紧张素原基因A-20C位点AA,AC,CC基因型频率比较差异无显著性意义(高血压组分别为0.51,0.29,0.20;正常对照组分别为0.49,0.28,0.23,χ2=0.395,P=0.529)。A,C等位基因频率比较差异无显著性意义(高血压组分别为0.65,0.35;正常对照组分别为0.63,0.37,χ2=0.015,P=0.904)。③两组血管紧张素原基因A-6G位点AA,AG,GG基因型频率比较差异无显著性意义(高血压组分别为0.50,0.33,0.17;正常对照组分别为0.55,0.34,0.11,χ2=1.924,P=0.165)。A,G等位基因频率比较差异无显著性意义(高血压组分别为0.66,0.34;正常对照组分别为0.72,0.28,χ2=1.728,P=0.189)。④高血压组协同存在血管紧张素原基因A-20C基因型CC时,血管紧张素原基因A-6G基因型GG频率稍高于正常对照组,但差异无显著性意义(χ2=2.395,P=0.122,OR=7.52,95%CI0.014~1.250),高血压组G等位基因明显高于正常对照组(分别为0.37,0.22,χ2=4.658,P=0.034),携带该等位基因的蒙古族人群发生原发性高血压的相对危险度升高(OR=2.80,95%CI1.087~7.271)。结论:血管紧张素原基因A-20C和A-6G单核苷酸多态性与蒙古族人群原发性高血压相关,并可能具有协同作用。 相似文献
92.
93.
94.
Irtan S Saint-Marcoux F Rousseau A Zhang D Leroy V Marquet P Jacqz-Aigrain E 《Therapeutic drug monitoring》2007,29(1):96-102
Cyclosporine A (CsA) is an immunosuppressive drug widely used in pediatric renal graft recipients. Its large interindividual pharmacokinetic variability and narrow therapeutic index render therapeutic drug monitoring necessary. However, information about CsA pharmacokinetics is scarce and no population pharmacokinetic (popPK) studies in these populations have been reported so far. to the objectives of this study were 1) to develop a PKpop model and identify the individual factors influencing the variability of CsA pharmacokinetics in pediatric kidney recipients; and 2) to build a Bayesian estimator allowing the estimation of the main PK parameters and exposure indices to CsA on the basis of a limited sampling strategy (LSS). The popPK analysis was performed using the NONMEM program. A total of 256 PK profiles of CsA collected in 98 pediatric renal transplant patients (mean age 9.7 +/- 4.5 years old) within the first year posttransplantation were studied. A 2-compartment model with first-order elimination, and Erlang distribution to describe the absorption phase, fitted the data adequately. For Bayesian estimation, the best LSS was determined based on its performance in estimating area under the concentration-time curve (AUC0-12h) and validated in an independent group of 20 patients. The popPK analysis identified body weight and posttransplant delay as individual factors influencing the apparent central volume of distribution and the apparent clearance, respectively. Bayesian estimation allowed accurate prediction of AUC0-12h using predose, C1h, and C3h blood samples with a mean bias between observed and estimated AUC of 0.5% +/- 11% and good precision (root mean square error = 10.9%). This article reports the first popPK study of CsA in pediatric renal transplant patients. It confirms the reliability and feasibility of CsA AUC estimation in this population. The body weight and the posttransplantation delay were identified to influence PK interindividual variability of CsA and were included in the Bayesian estimator developed, which could be helpful in further clinical trials. 相似文献
95.
Lars L Andersen Sannie V Thorsen Mona Larsen Emil Sundstrup Ccile RL Boot Reiner Rugulies 《Scandinavian journal of work, environment & health》2021,47(1):15
Objectives:The demographic changes in Europe underline the need for an extension of working lives. This study investigates the importance of physical work demands and psychosocial work factors for working beyond the state pension age (65 years).Methods:We combined data from three cohorts of the general working population in Denmark (DWECS 2005 and 2010, and DANES 2008), where actively employed workers aged 55–59 years replied to questionnaires about work environment and were followed until the age of 66 years in the Danish AMRun register of paid employment. Using logistic regression analyses, we calculated prevalence ratios (PR) and 95% confidence intervals (CI) for the association between physical and psychosocial work factors and working beyond state pension age, adjusted for age, sex, cohort, cohabiting, sector, income, vocational education, working hours, lifestyle, and previous sickness absence.Results:Of the 2884 workers aged 55–59 years, 1023 (35.5%) worked beyond the state pension age. Higher physical work demands was associated with a lower likelihood (PR 0.69, 95% CI 0.58–0.82) and a good psychosocial work environment was associated with higher likelihood (average of 7 items: PR 1.81, 95% CI 1.49–2.20) of working beyond state pension age. Stratified analyses did not change the overall pattern, ie, a good overall psychosocial work environment – as well as several specific psychosocial factors – increased the likelihood of working beyond state pension age, both for those with physically active and seated work.Conclusion:While high physical work demands was a barrier, a good psychosocial work environment seems to facilitate working beyond state pension age, also for those with physically active work. 相似文献
96.
Consequences of blood loss on growth of artificial metastases 总被引:2,自引:0,他引:2
S K Singh R L Marquet R W de Bruin W C Hop D L Westbroek J Jeekel 《The British journal of surgery》1988,75(4):377-379
Previous studies have shown that lung metastases from a nonimmunogenic sarcoma (LS175) in BN (homozygous for RTln) rats were stimulated by blood transfusions. Enhanced growth was also observed after abdominal surgery combined with allogeneic blood transfusions while syngeneic blood transfusions had no effect. These experimental findings have been confirmed in retrospective clinical studies. The allogeneic blood transfusion effect may be avoided in cancer patients by autologous blood transfusions although this implies blood donation before surgery. The aim of the present study was to investigate the effect of blood loss before surgery on formation ('take') of lung colonies, and on the outgrowth of established metastases in the BN rat model. These aspects of tumour behaviour were also investigated in rats undergoing surgery, or receiving blood transfusion, or both, after blood loss. The results indicate that blood loss has a profound stimulating effect on the growth of established metastases, but not on the 'take' of tumour cells. This stimulating effect was also present when blood loss was combined with surgery, while previously surgery alone was found to have no effect. Allogeneic and syngeneic transfusions in combination with blood loss both had a strong stimulating effect on growth of established lung metastases. The results indicate that blood loss may be an important factor in determining the outcome of metastatic growth. 相似文献
97.
Surface IgM+B220+ B cell precursors can be categorized as either leukosialin (CD43/S7) negative (late stage pre-B cells) or positive (pro-B/early pre-B cells). In autoimmune New Zealand Black (NZB) mice, bone marrow small pre-B cells (IgM-CD43-B220+) and pro-B/early pre-B cells (IgM-CD43+B220+) declined significantly with age. In particular, subpopulations of pro-B/early pre-B cells expressing the heat stable antigen (HSA) were found in lower proportions with age. Significant decreases in interleukin-7 (IL-7) colony forming units (CFU) were also seen in NZB mice by 6 to 8 months of age and accompanied alterations in the numbers of pro-B and pre-B cells in bone marrow. Concomitant with reduced numbers of B lineage precursor cells and IL-7 CFU in vivo, NZB mice produced serum IgM antibodies that strongly inhibited IL-7 CFU responses in vitro. Two monoclonal IgM antibodies (5G9, 2F5) derived from LPS stimulated 10-month-old NZB splenocytes recognized pre-B cell surface antigens on both pre-B cell lines and on IL-7 stimulated bone marrow pro-B/pre-B cells. However, these monoclonal antibodies (MoAb) failed to significantly stain ex vivo bone marrow cells. The 5G9 and 2F5 MoAbs also partially inhibited IL-7 CFU in vitro. These results suggest that NZB bone marrow becomes increasingly deficient in B cell precursors and especially in IL-7 responsive pre-B cells with age. IgM serum antibodies and monoclonal IgM antibodies derived from older NZB mice inhibit pre-B cell growth to IL-7. The production of such autoantibodies may interfere with B cell development in aging NZB mice by preventing IL-7-mediated proliferation. 相似文献
98.
C. Sabot P. Marquet J. Debord N. Carpentier L. Merle G. Lachâtre 《European journal of clinical pharmacology》1998,54(2):171-175
Objective: To develop a population pharmacokinetics of vinorelbine in a population of non-small-cell lung cancer (NSCLC) patients using
a Bayesian estimation in order to calculate for any further patient, individual pharmacokinetic parameters from few blood
samples. Methods: Vinorelbine was given by a 15-min infusion (30 mg · m−2) to eight patients with NSCLC. Its serum concentration was determined by HPLC and its pharmacokinetics was described by a
three-compartment open model with elimination from the central compartment. Volume of the central compartment (V1) and rate constants (k10, k12, k21, k13, k31) were selected as population pharmacokinetic parameters and computed by non-linear regression (two-step approach) from 14
to 18 concentration measurements per course. Subsequently, these parameters were used by the Bayesian estimator to calculate
individual pharmacokinetics from only 2 or 3 measured concentrations. Results: The population mean values (CV%) of V1, k10, k12, k21, k13, k31, CL, t
1/2 were respectively 21 l (55%), 3.2 h−1 (29%), 7.7 h−1 (74%), 1.3 h−1 (67%), 4.7 h−1 (53%), 0.04 h−1 (20%), 57 l · h−1 (31%) and 43 h (36%). The comparison of results obtained from the Bayesian estimator and from the three-compartment model
showed that CL and t
1/2 were well predicted (relative deviation: ±12 to 22%) by the Bayesian method using only two blood samples. Conclusion: We demonstrated that Bayesian estimation allows, at minimal cost and minimal disturbance for the patient, the determination
of several vinorelbine pharmacokinetic parameters and therefore dose adaptation from as few as two drug concentrations, measured
at 6 h and 24 h after infusion.
Received: 4 July 1997 / Accepted in revised form: 15 November 1997 相似文献
99.
100.